VK2735 for Weight Management Phase 3
Trial details
- Registry ID
- NCT07104500
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| VK2735 for Weight Management Phase 3NCT07104500 | VKTX | Phase 3 | Active not recruiting | 2027-07-01Estimated |
| VK2735 for Weight Management Phase 2NCT06068946 | VKTX | Phase 2 | Completed | 2024-02-27Actual |
| VK2735 for Weight Management Phase 2 (Venture Oral Dosing)NCT06828055 | VKTX | Phase 2 | Completed | 2025-06-24Actual |
| VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)NCT07104383 | VKTX | Phase 3 | Active not recruiting | 2027-07-01Estimated |
| Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)NCT07868835 | VKTX | Phase 3 | Recruiting | 2028-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |